DaVita
DVA
#2034
Rank
NZ$16.87 B
Marketcap
NZ$252.44
Share price
-0.24%
Change (1 day)
1.78%
Change (1 year)
DaVita Inc. is an American company providing dialysis services for patients with chronic and acute kidney failure.

EPS for DaVita (DVA)

EPS in 2025 (TTM): NZ$17.32

According to DaVita's latest financial reports the company's current EPS (TTM) is NZ$16.93. In 2024 the company made an earnings per share (EPS) of NZ$18.45 an increase over its 2023 EPS that were of NZ$12.73.

EPS history for DaVita from 2012 to 2025

Annual EPS

Year EPS Change
2025 (TTM)NZ$17.32-6.11%
2024NZ$18.4544.94%
2023NZ$12.7327.26%
2022NZ$10.00-35.56%
2021NZ$15.5244.1%
2020NZ$10.7719.7%
2019NZ$9.00540.48%
2018NZ$1.41-76.07%
2017NZ$5.87-19.31%
2016NZ$7.28242.52%
2015NZ$2.12-62.87%
2014NZ$5.7213.43%
2013NZ$5.048.45%
2012NZ$4.65

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Universal Health Services
UHS
NZ$35.71 110.97%๐Ÿ‡บ๐Ÿ‡ธ USA
LabCorp
LH
NZ$17.15 1.28%๐Ÿ‡บ๐Ÿ‡ธ USA
Tenet Healthcare
THC
NZ$24.59 45.26%๐Ÿ‡บ๐Ÿ‡ธ USA
Pediatrix Medical Group
MD
NZ$3.18-81.24%๐Ÿ‡บ๐Ÿ‡ธ USA